Sympathetic overactivity in the development of eyelid retraction in a patient with euthyroid Graves' disease evaluated by accommodation

被引:8
|
作者
Hamada, N
Okamoto, Y
Yoshida, H
Tsumura, K
Nakamura, Y
Noh, JY
机构
[1] Sumire Hosp, Joto Ku, Osaka 5360001, Japan
[2] Osaka City Univ, Sch Med, Dept Internal Med 2, Abeno Ku, Osaka 5450051, Japan
[3] NTT, Osaka Cent Hlth Adm Ctr, Kita Ku, Osaka 5300005, Japan
[4] Ito Hosp, Shibuya Ku, Tokyo 1508308, Japan
关键词
eyelid retraction; euthyroid Graves' disease; accommodation; sympathetic overactivity; guanethidine;
D O I
10.1507/endocrj.47.623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is known that measurement of accommodation is useful to evaluate the sympathetic activity of intraocular muscles. To find if sympathetic overactivity is involved in eyelid retraction in euthyroid Graves' disease, we measured accommodation in two patients with this disease, whose serum concentrations of free T3, free T4 and TSH were within reference ranges. Accommodation was measured with a computer-assisted infrared optometer with an iriscoder, and the results were expressed as the change in the eye's refractive power (in diopters) in response to the movement of a target beam. In patient 1, the accommodation amplitude was low, indicating sympathetic overactivity. This amplitude rose to near the reference range when timolol maleate drops were used, and the eyelid retraction disappeared when guanethidine drops were given. During the use of guanethidine drops, accommodation remained normal. In patient 2, who had normal accommodation, eyelid retraction did not change with guanethidine administration, but improved with intravenous methylprednisolone pulse therapy. These two cases suggested that even in euthyroid Graves' disease, eyelid retraction is caused by sympathetic overactivity, and pulse therapy with methylprednisolone may be effective for eyelid retraction when guanethidine drops are not effective.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 32 条
  • [21] DEVELOPMENT OF GRAVES DISEASE IN A PATIENT WITH AN AUTONOMOUS THYROID NODULE
    ROSENFELD, PS
    SOUTHERN MEDICAL JOURNAL, 1970, 63 (05) : 549 - +
  • [22] LEVATOR-PALPEBRAE-SUPERIORIS MUSCLE - MR EVALUATION OF ENLARGEMENT AS A CAUSE OF UPPER EYELID RETRACTION IN GRAVES-DISEASE
    OHNISHI, T
    NOGUCHI, S
    MURAKAMI, N
    NAKAHARA, H
    HOSHI, H
    JINNOUCHI, S
    FUTAMI, S
    NAGAMACHI, S
    WATANABE, K
    RADIOLOGY, 1993, 188 (01) : 115 - 118
  • [23] Rapid Development of Graves' Ophthalmopathy After Treatment With Ipilimumab and Recurrence With Pembrolizumab in a Patient With Previously Treated Graves' Disease
    Rhea, Logan
    Yoon, Ji Won
    Jang, Sekwon
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (12) : 747 - +
  • [24] Development of Graves’ disease in a patient under immunosuppressive therapy after liver transplantation
    T. Bednarczuk
    U. Makowska
    Janusz Nauman
    Journal of Endocrinological Investigation, 2003, 26 : 257 - 260
  • [25] Development of Graves' disease in a patient under immunosuppressive therapy after liver transplantation
    Bednarczuk, T
    Makowska, U
    Nauman, J
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (03) : 257 - 260
  • [26] Development of postpartum Graves' disease and type 1 diabetes after delivery in a patient with gestational diabetes
    Negishi, Mayumi
    Shimomura, Kenju
    Proks, Peter
    Nakahara, Rieko
    Murakami, Masami
    Shimomura, Yohnosuke
    Kobayashi, Isao
    JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (04) : 328 - 330
  • [27] DEVELOPMENT OF GRAVES OPHTHALMOPATHY AND UVEITIS AFTER RADIOIODINE THERAPY FOR GRAVES-DISEASE IN A PATIENT WITH HTLV-I-ASSOCIATED MYELOPATHY (HAM)
    OZAWA, Y
    MIGITA, M
    WATANABE, T
    OKUDA, I
    TAKESHITA, A
    TAKAGI, A
    SHISHIBA, Y
    INTERNAL MEDICINE, 1994, 33 (09) : 564 - 568
  • [28] WHY DOES THE PATIENT WITH GRAVES' DISEASE REMAIN EUTHYROID/MILDLY HYPERTHYROID FOLLOWING TOTAL THYROIDECTOMY - THE ROLE OF THYROTROPIN RECEPTOR ANTIBODIES (TRAb) AND VESTIGIAL REMNANTS OF THE THYROGLOSSAL TRACT
    Cigrovski-Berkovic, Maja
    Solter, Darko
    Solter, Miljenko
    ACTA CLINICA CROATICA, 2008, 47 (03) : 171 - 174
  • [29] Development and Validation of a Patient Symptom Questionnaire to Facilitate Early Diagnosis of Thyroid-Associated Orbitopathy in Graves' Disease
    Mohaseb, Kam
    Linder, Mark
    Rootman, Jack
    Wilkins, G. E.
    Schechter, Martin T.
    Dolman, Peter J.
    Singer, Joel
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2008, 27 (06): : 419 - 425
  • [30] DEVELOPMENT OF A HUMAN MONOCLONAL-ANTIBODY FROM A GRAVES-DISEASE PATIENT THAT IDENTIFIES A NOVEL THYROID MEMBRANE ANTIGEN
    BAKER, JR
    SAUNDERS, NB
    KAULFERSCH, W
    BURMAN, KD
    JOURNAL OF IMMUNOLOGY, 1988, 140 (08): : 2593 - 2599